Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18739658 [patent_doc_number] => 20230348620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR P95HER2 AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/999769 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38169 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999769 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999769
CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR P95HER2 AND USES THEREOF May 27, 2021 Pending
Array ( [id] => 20742965 [patent_doc_number] => 12642847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-06-02 [patent_title] => Human monoclonal antibodies to Venezuelan equine encephalitis virus and uses therefor [patent_app_type] => utility [patent_app_number] => 17/999366 [patent_app_country] => US [patent_app_date] => 2021-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26249 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999366 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999366
Human monoclonal antibodies to Venezuelan equine encephalitis virus and uses therefor May 26, 2021 Issued
Array ( [id] => 18413178 [patent_doc_number] => 11667711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => Anti-human LAG-3 antibodies and their use in immunohistochemistry (IHC) [patent_app_type] => utility [patent_app_number] => 17/331344 [patent_app_country] => US [patent_app_date] => 2021-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10907 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17331344 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/331344
Anti-human LAG-3 antibodies and their use in immunohistochemistry (IHC) May 25, 2021 Issued
Array ( [id] => 18467055 [patent_doc_number] => 20230201335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => Antigen Presenting Polypeptide Complexes and Methods of Use Thereof [patent_app_type] => utility [patent_app_number] => 17/927477 [patent_app_country] => US [patent_app_date] => 2021-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71805 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927477 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/927477
Antigen Presenting Polypeptide Complexes and Methods of Use Thereof May 25, 2021 Pending
Array ( [id] => 18496189 [patent_doc_number] => 20230218744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR [patent_app_type] => utility [patent_app_number] => 18/000380 [patent_app_country] => US [patent_app_date] => 2021-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11583 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000380 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/000380
HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR May 25, 2021 Pending
Array ( [id] => 17784728 [patent_doc_number] => 11407840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-09 [patent_title] => Antibodies to M(H)DM2/4 and their use in diagnosing and treating cancer [patent_app_type] => utility [patent_app_number] => 17/328597 [patent_app_country] => US [patent_app_date] => 2021-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 54839 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328597 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/328597
Antibodies to M(H)DM2/4 and their use in diagnosing and treating cancer May 23, 2021 Issued
Array ( [id] => 17080649 [patent_doc_number] => 20210275655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS [patent_app_type] => utility [patent_app_number] => 17/327193 [patent_app_country] => US [patent_app_date] => 2021-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57673 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327193 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/327193
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS May 20, 2021 Abandoned
Array ( [id] => 19043594 [patent_doc_number] => 11932678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-19 [patent_title] => Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers [patent_app_type] => utility [patent_app_number] => 17/314650 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 52133 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314650 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/314650
Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers May 6, 2021 Issued
Array ( [id] => 17082082 [patent_doc_number] => 20210277088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS [patent_app_type] => utility [patent_app_number] => 17/314688 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52243 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314688 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/314688
Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers May 6, 2021 Issued
Array ( [id] => 17082081 [patent_doc_number] => 20210277087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS [patent_app_type] => utility [patent_app_number] => 17/314668 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52251 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314668 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/314668
Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers May 6, 2021 Issued
Array ( [id] => 20701392 [patent_doc_number] => 12624092 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-05-12 [patent_title] => Compositions and methods for membrane protein structure determination [patent_app_type] => utility [patent_app_number] => 17/997720 [patent_app_country] => US [patent_app_date] => 2021-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 8 [patent_no_of_words] => 6452 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997720 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/997720
Compositions and methods for membrane protein structure determination May 5, 2021 Issued
Array ( [id] => 19608905 [patent_doc_number] => 12157771 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-03 [patent_title] => Proteins binding NKG2D, CD16 and CLEC12A [patent_app_type] => utility [patent_app_number] => 17/308691 [patent_app_country] => US [patent_app_date] => 2021-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 483 [patent_figures_cnt] => 1064 [patent_no_of_words] => 111584 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17308691 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/308691
Proteins binding NKG2D, CD16 and CLEC12A May 4, 2021 Issued
Array ( [id] => 20548795 [patent_doc_number] => 12559575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-24 [patent_title] => Isoform-independent antibodies to lipoprotein(a) [patent_app_type] => utility [patent_app_number] => 17/921621 [patent_app_country] => US [patent_app_date] => 2021-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 18 [patent_no_of_words] => 17200 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17921621 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/921621
Isoform-independent antibodies to lipoprotein(a) Apr 26, 2021 Issued
Array ( [id] => 18738014 [patent_doc_number] => 20230346919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => SARS COV-2 VACCINES AND HIGH THROUGHPUT SCREENING ASSAYS BASED ON VESICULAR STOMATITIS VIRUS VECTORS [patent_app_type] => utility [patent_app_number] => 17/918792 [patent_app_country] => US [patent_app_date] => 2021-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41617 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -65 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918792 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/918792
SARS COV-2 VACCINES AND HIGH THROUGHPUT SCREENING ASSAYS BASED ON VESICULAR STOMATITIS VIRUS VECTORS Apr 13, 2021 Pending
Array ( [id] => 17007082 [patent_doc_number] => 20210238243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS [patent_app_type] => utility [patent_app_number] => 17/229592 [patent_app_country] => US [patent_app_date] => 2021-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39428 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17229592 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/229592
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Apr 12, 2021 Issued
Array ( [id] => 17170378 [patent_doc_number] => 20210324048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => COMPOUNDS SPECIFIC TO CORONAVIRUS S PROTEIN AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/226153 [patent_app_country] => US [patent_app_date] => 2021-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 102577 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17226153 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/226153
Compounds specific to coronavirus S protein and uses thereof Apr 8, 2021 Issued
Array ( [id] => 20957744 [patent_doc_number] => 12728159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-09-08 [patent_title] => Coronavirus vaccines compositions and method of using same [patent_app_type] => utility [patent_app_number] => 17/914293 [patent_app_country] => US [patent_app_date] => 2021-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 8 [patent_no_of_words] => 8596 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914293 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/914293
CORONAVIRUS VACCINES COMPOSITIONS AND METHOD OF USING SAME Mar 22, 2021 Pending
Array ( [id] => 18366066 [patent_doc_number] => 20230147657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR HUMAN CD45RC AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/912726 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912726 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/912726
CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR HUMAN CD45RC AND USES THEREOF Mar 18, 2021 Pending
Array ( [id] => 16946738 [patent_doc_number] => 20210205429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint Inhibitor [patent_app_type] => utility [patent_app_number] => 17/205634 [patent_app_country] => US [patent_app_date] => 2021-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205634 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/205634
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint Inhibitor Mar 17, 2021 Abandoned
Array ( [id] => 18312687 [patent_doc_number] => 20230116587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => MONOCLONAL ANTIBODY AGAINST NOVEL CORONAVIRUS AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/911326 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7799 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911326 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/911326
MONOCLONAL ANTIBODY AGAINST NOVEL CORONAVIRUS AND APPLICATION THEREOF Mar 11, 2021 Pending
Menu